JALYN (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the JALYN drug offered from GlaxoSmithKline LLC. This 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA],Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | dutasteride and tamsulosin hydrochloride |
| SUBSTANCE NAME: | DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA],Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-06-21 |
| END MARKETING DATE: | 0000-00-00 |
JALYN HUMAN PRESCRIPTION DRUG Details:
| Item Description | JALYN from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .5; .4(mg/1; mg/1) |
| START MARKETING DATE: | 2010-06-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0173-0809_f8541685-f609-4814-926b-f4350a5f982a |
| PRODUCT NDC: | 0173-0809 |
| APPLICATION NUMBER: | NDA022460 |
Other DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
